drugset / Trial / NCT04509336

Orphenadrine Versus Baclofen in Treatment of Muscle Cramps in Cirrhotic Patients

NCT04509336

Terminated 5 enrolled Mansoura University
RandomizedParallel-groupDouble-blindTreatment

Summary

Muscle cramps are commonly affects patients with cirrhosis. It adversely influences the quality of life of cirrhotic patients. Treatment of muscle cramps still challenging owing to the diversity of the responsible pathophysiological mechanisms.The effectiveness of baclofen and orphenadrine in controlling muscle cramps in cirrhotic patients has been presented in recent randomised controlled clinical trials;however, the comparative efficacy and safety between these two therapeutic options has not been previously investigated.

Timeline

Start
2020-08-20
Primary completion
2020-12-01
Completion
2021-09-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Baclofen Small molecule 10 mg
Subject Orphenadrine Small molecule 100 mg

Indications